Phocas Financial »

Denali Therapeutics shares owned by Phocas Financial

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Phocas Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 71k 25.72

More positions owned by Phocas Financial

Ducommun Incorporated (DCO)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Aar (AIR)
Materion Corporation (MTRN)
Stonex Group (SNEX)
Ralliant Corp (RAL)
Wintrust Financial Corporation (WTFC)
National Energy Services Reu SHS (NESR)
Ameris Ban (ABCB)
Columbia Banking System (COLB)
Alerus Finl (ALRS)
Meta Financial (CASH)
Carpenter Technology Corporation (CRS)
SkyWest (SKYW)
Preferred Bk Los Angeles Ca Com New (PFBC)

View all positions for Phocas Financial

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Goldman Sachs Group
Geode Capital Management
Holocene Advisors
Baker Bros. Advisors
Ubs Global Asset Management Americas
UBS Group
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Denali Therapeutics